Fundz

Who to call at Diag-Nose.io, and when

Fundz watches for the moments Diag-Nose.io starts buying, and tells you who to reach.

  • An alert the day Diag-Nose.io raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Diag-Nose.io, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchDiag-Nose.io Launches RhinoMAP™ Platform and ABEL Microsampler™ to Transform Respiratory Diagnostics.

Jan 30, 2025
BethlehemBiotechnologyHealth CareArtificial IntelligenceTherapeuticsHealth Diagnostics

Product Description

Diag-Nose.io, following a successful $2M seed round, has developed the RhinoMAP™ platform and ABEL Microsampler™ to revolutionize the management of chronic respiratory diseases by providing precision-matched treatments based on unique biological profiles.

Company Information

Company

Diag-Nose.io

Location

Bethlehem, Pennsylvania, United States

About

Diag-Nose.io is a biotechnology company founded in 2020, focusing on precision diagnostic and drug discovery solutions for chronic respiratory diseases. Their technology integrates advanced proteomics, computational biology, and AI to enhance treatment prescription and accelerate new therapy development. The flagship platform, RhinoMAP™, aims to predict respiratory disease activity and monitor treatment efficacy. Diag-Nose.io's innovative approach seeks to transform respiratory healthcare through data-driven personalized care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Diag-Nose.io ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brian hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Diag-Nose.io's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Diag-Nose.io shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.